Eli Lilly said on Thursday its experimental pill, orforglipron, led to weight loss of nearly 8% at the highest dose and ...

Eli Lilly claims that the pill, named orforglipron, is alternative to injections and also the first small molecule oral GLP-1 to succeed in a Phase 3 trial., Health News - Times Now ...

Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

A new study has found that the weight-loss drug tirzepatide can help people lose a significant amount of weight and keep it ...

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are ...

Pfizer has decided to halt the development of its potential once-daily pill treatment for obesity due to safety concerns ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

The drugmaker said Tuesday that it would stop studying danuglipron after a participant in one of its trials experienced a ...

For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...